logo
Select company
Select metric
$ -46.09MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
13
Sector
35
Industry
49
History
18
$ 2.65Close
$ 1.97 - $ 5.81 52-Week Range
Ticker Information

Ticker

CDXS

Company Name

CODEXIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CODEXIS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CDXS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 8.03M$ -54.12M$ -46.09M
3/31/2025$ 8.01M$ -63.6M$ -55.59M
12/31/2024$ 8.13M$ -54.85M$ -46.72M
9/30/2024$ 8.07M$ -56.12M$ -48.05M
6/30/2024$ 8.54M$ -75.31M$ -66.77M
3/31/2024$ 9.23M$ -65.06M$ -55.83M
12/31/2023$ 9.92M$ -76.17M$ -66.25M
9/30/2023$ 10.62M$ -81.47M$ -70.85M
6/30/2023$ 10.75M$ -56.55M$ -45.8M
3/31/2023$ 10.55M$ -47.57M$ -37.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CODEXIS INC's latest trailing twelve months (TTM) EBITDA stands at $ -15.81M.
  • Over the past 5 years, CODEXIS INC's average EBITDA has been $ -35.28M.
  • The median EBITDA for CODEXIS INC during this period was $ -30.04M
  • CODEXIS INC reached its highest EBITDA over the past 5 years at $ -9.57M.
  • The lowest EBITDA recorded by CODEXIS INC in the same timeframe $ -70.85M

CODEXIS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SCPH : SCPHARMACEUTICALS INC $ -85.42MLXRX : LEXICON PHARMACEUTICALS INC $ -107.44MENTA : ENANTA PHARMACEUTICALS INC $ -82.41MADCT : ADC THERAPEUTICS SA $ -115.26MTHTX : THERATECHNOLOGIES INC $ 7.31MFENC : FENNEC PHARMACEUTICALS INC $ -9.19MTRDA : ENTRADA THERAPEUTICS INC $ -73MXOMA : XOMA ROYALTY CORP $ -2.98MEDIT : EDITAS MEDICINE INC $ -235.43MCSBR : CHAMPIONS ONCOLOGY INC $ 4.42M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for CODEXIS INC is calculated as follows: EBIT [ $ -20.39M ] + DepAmor [ $ 4.58M ]
(=) EBITDA [ $ -15.81M ]

CDXS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -70.85M

Minimum

Sep 30, 2023

$ -9.57M

Maximum

Sep 30, 2021

$ -35.28M

Average

$ -30.04M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M